Immunochemotherapy, Surgery or Chemoradiation, and Durvalumab for Stage IIIA/B NSCLC

NCT06810609 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

176

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer Non-Small Cell Cancer (NSCLC)

Interventions

PROCEDURE: surgery (any volume) and / or pharmaceuticals treatment initiated or planned or only dynamic observation, in accordance with current clinical guidelines
RADIATION: Chemoradiotherapy
DRUG: Immunotherapy

Sponsor

University Hospital, Bonn